Monthly FDA Guidance and Regulatory News Review - March 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
How Veristat Helped a Global Pharma Company Navigate Complex Medical Writing Challenges
Learn how Veristat's expert medical writing team supported a global specialty pharmaceutical...
Regulatory Guidance Monthly Review - February 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Navigating the IND Submission Labyrinth: A Veristat Success Story
At Veristat, we pride ourselves on transforming challenges into triumphs, particularly in the...
Regulatory Guidance Monthly Review - January 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Veristat Joined the Battle to Fight Rare Cancers for the Tenth Year Running with Cycle for Survival 2024
We did it again! A Successful Cycle for Survival Ride Raising Over $90K To Support Rare Cancer...
Pursuing Breakthrough Therapies for Rare Metabolic Diseases: Veristat's Role in a Landmark Clinical Study
At Veristat, we recently embarked on an ambitious journey alongside a biotech organization...
Regulatory Guidance Monthly Review - December 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Elevating CNS Drug Development: Veristat’s Agile Approach in Medical Writing and Project Management
Precision and efficiency are key in the intricate world of CNS drug development. Veristat's recent...